Congratulations to the SNaPP Trial team who started recruitment of their MRFF funded study this July, enrolling 5 participants already at the lead site, The Royal Melbourne Hospital, in their first week.
Congratulations to the CALIPSO Trial team who started recruitment of their MRFF funded study this week February, enrolling the first 2 participants yesterday at the lead site, The Alfred.
Congratulations to the BONANZA Trial (Brain Oxygen Neuromonitoring in Australia and New Zealand Assessment) team with three new sites going live in 2021
Tweetchats with PRAXIS and Australian Clinical Trials Alliance [repost from ACTA Newsletter]
Congratulations to the START Trial team who started the pilot phase of their MRFF funded study today, enrolling the first 14 residents
Congratulations to PADDI Trial for reaching the recruitment target of 8880 patients across 56 sites worldwide today
Congratulations Prof Paul Myles & the RELIEF trial team for being a finalist in the 2019 ACTA Clinical Trial of the Year Award.
The Research Path office will be closed for the festive season from Monday 24 December and reopen on Monday 7 January, 2019.
Wishing you all a restful and reinvigorating break and looking forward to working with you in 2019.
The Intensive Nutrition Therapy comparEd to usual care iN criTically ill adults - a randomised controlled trial. The Alfred Hospital recruited their first patient today just four months after developed started on this highly customised CTMS.
Following the completion of recruitment for FEISTY Adult Pilot in September 2017, the team at Gold Coast University Hospital have now launch FEISTY Junior at sites across Queensland.
This afternoon, around 2.30pm Melbourne time, SPICE III Study reached its recruitment target of 4000 patients across 67 sites.
ROCKet Trial officially commenced today with recruitment of the first patient at Austin Health.
Yesterday the FEISTY Plot Trial reached target recruitment of 100 patients well ahead of target. The first patient was recruited on January 3rd 2017.
Three Monash University clinicians are making news this week with the initial results from the bidirectional cannula trial: http://www.9news.com.au/health/2017/08/15/00/06/melbourne-invention-saves-lives-and-limbs.
ATACAS (Aspirin and Tranexamic Acid for Coronary Artery Surgery) has been awarded the prestigious Clinical Trial of the Year Award at the Clinical Trials 2017 National Tribute and Awards Ceremony in Sydney this month. Federal Minister for Health, Greg...
The Australian Government has released the National Science Statement as part of the National Innovation and Science Agenda.
We welcome the increased focus of science and innovation and investment from this Government in, particularly in health and...
Coming up in November are the NHMRC Symposium on Research Translation and Australian Clinical Trials Alliance (ACTA) Summit - Impact.
We have just returned from beautiful Coogee, in Sydney NSW, where we participated in the ANZCA CTN Annual Strategic Workshop.
We’ve recently moved into our new office in Footscray at 67 Whitehall St
Australian Clinical Trials Alliance hosted the inaugural Trial of the Year Award on Friday 20th May 2016 to coincide with International Clinical Trials Day.
Director Adam Meehan was pleased to attend the Platform Trials Workshop hosted by Monash University and ANZIC CTG on Saturday May 7th. The workshop covered the key components and concepts of a platform trial, current platform trials, as well as when...
Congratulations to the PADDI Trial team for recruiting their first patient today at The Alfred Hospital.
Just in time for the summer holidays, The Neurotrauma Evidence Translation (NET) Program has finished the the final stage of the Changing Practice Theme: Mild Traumatic Brain Injury (mTBI) in the Emergency Department. This cluster randomised trial...
We attended the very successful ACTA 2015 Symposium recently. A big thank you to the conveners, organisers and delegates
The Medical Research Future Fund was passed by the Senate yesterday, a multi-billion dollar program to invest in and strengthen Australia’s standing as a leader in medical research.
A recent article published in the MJA has found that heart disease, asthma, and new National Health Priority Areas, obesity and dementia, have disproportionately less clinical trials relative to their disease burden in Australia, especially when compared...
With the NHMRC 2016 project grants announcement only a few months away, now is a good time to get quotes for your clinical trial software solution. Early engagement with a software partner will enable you to kick off the project this December, so you...
The open access to clinical trial data conversations recently reached our Australian screens when Catalyst discussed Tamiflu on March 3rd
New site launched!
The ANZICS/ACCCN Annual Scientific Meeting on Intensive Care was held at the Melbourne Convention and Exhibition Centre from October 9th - 11th.
Two of the team members from the Sedation Practice in Intensive Care Evaluation (SPICE III) Program presented...
University of Melbourne led study, MUM SIZE, was featured on Chanel 9 News on August 7th. The study is being undertaken in collaboration with 7 Victorian hospitals and aims to to increase understanding of the best ways to care and plan for obese women...